FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Alberts

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Steven R Alberts
Update on the optimal management of patients with colorectal liver metastases.
Steven R Alberts; John K Camoriano; James R Enger; Gist H Farr; David B Johnson; Bruce W Morlan; Joel M Reid; Thomas E Seay; George P Kim
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.
Kunal C Kadakia; Paul J Limburg; Charles L Loprinzi; Paul J Novotny; Clark C Otley; Steven R Alberts; Debra L Barton; Brent B Diekmann; Jeff A Sloan; Mark R Pittelkow
Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Alberts (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Steven R Alberts
Update on the optimal management of patients with colorectal liver metastases.
Critical reviews in oncology/hematology 2012;84(1):59-70.
2012: Steven R Alberts; John K Camoriano; James R Enger; Gist H Farr; David B Johnson; Bruce W Morlan; Joel M Reid; Thomas E Seay; George P Kim
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.
American journal of clinical oncology 2012;35(5):418-23.
2012: Kunal C Kadakia; Paul J Limburg; Charles L Loprinzi; Paul J Novotny; Clark C Otley; Steven R Alberts; Debra L Barton; Brent B Diekmann; Jeff A Sloan; Mark R Pittelkow
Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
Cancer 2012;118(8):2128-37.
2012: Steven R Alberts; Emily Chan; Gist H Farr; Sharlene Gill; Axel Grothey; Morton S Kahlenberg; Michelle R Mahoney; Margaret Mooney; Suresh Nair; Barbara A Pockaj; James T Quesenberry; Daniel J Sargent; Anthony F Shields; Frank A Sinicrope; Thomas C Smyrk; Stephen N Thibodeau; Thomas A Webb; Richard M Goldberg
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.
JAMA : the journal of the American Medical Association 2012;307(13):1383-93.
2012: John S Bolton; Gist H Farr; Tom R Fitch; Jyotsna Fuloria; Michelle R Mahoney; William J Maples; David M Nagorney; Michael J O'Connell; Joseph Rubin; Preston D Steen; Steven R Alberts
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
Clinical colorectal cancer 2012;11(1):31-7.
2011: Steven R Alberts; Graeme J Poston
Treatment advances in liver-limited metastatic colorectal cancer.
Clinical colorectal cancer 2011;10(4):258-65.
2011: Axel Grothey; Daniel A Nikcevich; Jeff A Sloan; John W Kugler; Peter T Silberstein; Todor Dentchev; Donald B Wender; Paul J Novotny; Umesh Chitaley; Steven R Alberts; Charles L Loprinzi
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(4):421-7.
2011: Michael G Haddock; Robert C Miller; Heidi Nelson; John H Pemberton; Eric J Dozois; Steven R Alberts; Leonard L Gunderson
Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer.
International journal of radiation oncology, biology, physics 2011;79(1):143-50.
2010: Aminah Jatoi; Gamini Soori; Nathan R Foster; Bradley K Hiatt; James A Knost; Tom R Fitch; Matthew D Callister; Francis C Nichols; Tim M Husted; Steven R Alberts
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(12):1994-8.
2010: Aminah Jatoi; Nathan R Foster; James R Egner; Patrick A Burch; Philip J Stella; Joseph Rubin; Shaker R Dakhil; Daniel J Sargent; Brian R Murphy; Steven R Alberts
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials.
International journal of oncology 2010;36(3):601-6.
2010: Steven R Alberts; Mark S Roh; Michelle R Mahoney; Michael J O'Connell; David M Nagorney; Lawrence Wagman; Thomas C Smyrk; Timothy L Weiland; Lily Lau Lai; Roderich E Schwarz; Roy Molina; Todor Dentchev; John S Bolton
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):853-8.
2009: Prema P Peethambaram; Michelle E Melisko; Kristine J Rinn; Steven R Alberts; Nicole M Provost; Lori A Jones; Robert B Sims; Lisa R C Lin; Mark W Frohlich; John W Park
A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5937-44.
2009: Mine S Cicek; Susan L Slager; Sara J Achenbach; Amy J French; Hilary E Blair; Stephanie R Fink; Nathan R Foster; Brian Kabat; Kevin C Halling; Julie M Cunningham; James Cerhan; Robert B Jenkins; Lisa A Boardman; Gloria M Petersen; Daniel J Sargent; Steven R Alberts; Paul J Limburg; Stephen N Thibodeau
Functional and clinical significance of variants localized to 8q24 in colon cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(9):2492-500.
2009: Steven R Alberts
Timing means everything, maybe.
Annals of surgical oncology 2009;16(9):2431-2.
2009: Terre A McJoynt; Muhanad A Hirzallah; Daniel V Satele; Jason H Pitzen; Steven R Alberts; S Vincent Rajkumar
Building a protocol expressway: the case of Mayo Clinic Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3855-60.
2009: George P Kim; Daniel J Sargent; Michelle R Mahoney; Kendrith M Rowland; Philip A Philip; Edith Mitchell; Abraham P Mathews; Tom R Fitch; Richard M Goldberg; Steven R Alberts; Henry C Pitot
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2848-54.
2009: Grace K Dy; Timothy J Hobday; Garth Nelson; Harold E Windschitl; Michael J O'Connell; Steven R Alberts; Richard M Goldberg; Daniel A Nikcevich; Daniel J Sargent
Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.
Clinical colorectal cancer 2009;8(2):88-93.
2009: Aminah Jatoi; Erin M Green; Kendrith M Rowland; Daniel J Sargent; Steven R Alberts
Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.
Oncology 2009;77(2):120-3.
2008: Steven R Alberts
Updated options for liver-limited metastatic colorectal cancer.
Clinical colorectal cancer 2008;7 Suppl 2():S58-62.
2008: Steven R Alberts; Lawrence D Wagman
Chemotherapy for colorectal cancer liver metastases.
The oncologist 2008;13(10):1063-73.
2008: Aminah Jatoi; Shaker R Dakhil; Nathan R Foster; Cynthia Ma; Kendrith M Rowland; Dennis F Moore; Anthony J Jaslowski; Sachdev P Thomas; Mark D Hauge; Patrick J Flynn; Philip J Stella; Steven R Alberts
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):516-20.
2008: Evanthia C Galanis; Stephanie K Carlson; Nathan R Foster; Val J. Lowe; Fernando Quevedo; Robert R McWilliams; Axel Grothey; Aminah Jatoi; Steven R Alberts; Joseph Rubin
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(5):979-84.
2007: Aminah Jatoi; James A Martenson; Nathan R Foster; howard mcleod; Bradley S Lair; Francis C Nichols; Loren K Tschetter; Dennis F Moore; Tom R Fitch; Steven R Alberts
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
American journal of clinical oncology 2007;30(5):507-13.
2007: Steven R Alberts
Therapeutic Advances in GI Malignancies--Fifth Annual Conference. 13-14 July 2007, Newport Beach, CA, USA.
IDrugs : the investigational drugs journal 2007;10(10):693-5.
2007: Hendrik T J Mantel; Charles B Rosen; Julie K Heimbach; Scott L Nyberg; Michael B Ishitani; James C Andrews; Michael A McKusick; Michael G Haddock; Steven R Alberts; Gregory J Gores
Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(10):1372-81.
2007: Grace K Dy; James E Krook; Erin M Green; Daniel J Sargent; Thierry Delaunoit; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Barbara A Pockaj; Robert P Sticca; Steven R Alberts; Henry C Pitot; Richard M Goldberg
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3469-74.
2007: Amanda C Ashley; Daniel J Sargent; Steven R Alberts; Axel Grothey; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Cancer 2007;110(3):670-7.
2007: Steven R Alberts; George P Kim; Michelle R Mahoney; Michael K Gornet; Joseph Rubin; Matthew Ames; Matthew P Goetz; Richard M Weinshilboum; Steven J Nicol; Richard M Goldberg
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.
Clinical colorectal cancer 2007;6(8):572-7.
2007: Michael G Haddock; Revathi Swaminathan; Nathan R Foster; Mark D Hauge; James A Martenson; John K Camoriano; Philip J Stella; Richard C Tenglin; Paul L Schaefer; Dennis F Moore; Steven R Alberts
Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(18):2567-72.
2007: Steven R Alberts; Gregory J Gores; George P Kim; Lewis Roberts; Michael L Kendrick; Charles B Rosen; Suresh T Chari; James A Martenson
Treatment options for hepatobiliary and pancreatic cancer.
Mayo Clinic proceedings. Mayo Clinic 2007;82(5):628-37.
2007: Cynthia Ma; Sumithra J Mandrekar; Steven R Alberts; Gary A Croghan; Aminah Jatoi; Joel M Reid; Lorelei J Hanson; Laura M Bruzek; Angelina D Tan; Henry C Pitot; Charles Erlichman; John J Wright; Alex A. Adjei
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies.
Cancer chemotherapy and pharmacology 2007;59(2):207-15.
2007: Steven R Alberts; Vera J Suman; Henry C Pitot; John K Camoriano; Joseph Rubin
Use of KW-2189, a DNA minor groove-binding agent, in patients with hepatocellular carcinoma: a north central cancer treatment group (NCCTG) phase II clinical trial.
Journal of gastrointestinal cancer 2007;38(1):10-4.
2006: Julie K Heimbach; Gregory J Gores; Michael G Haddock; Steven R Alberts; Rachel Pedersen; Walter K Kremers; Scott L Nyberg; Michael B Ishitani; Charles B Rosen
Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Transplantation 2006;82(12):1703-7.
2006: Smitha Patiyil; Steven R Alberts
Metastatic colorectal cancer: Therapeutic options.
Current treatment options in oncology 2006;7(5):389-98.
2006: Alvaro Moreno-Aspitia; Gerardo Colon-Otero; Antje Hoering; Ayalew Tefferi; Robert D Niedringhaus; Allen Vukov; Chin-Yang Li; David M Menke; Susan M Geyer; Steven R Alberts
Thalidomide therapy in adult patients with myelodysplastic syndrome. A North Central Cancer Treatment Group phase II trial.
Cancer 2006;107(4):767-72.
2006: Henry C Pitot; Alex A. Adjei; Joel M Reid; Jeff A Sloan; Pamela J Atherton; Joseph Rubin; Steven R Alberts; Barbara A Duncan; Louis Denis; Larry J Schaaf; Donghua Yin; Amarnath Sharma; Patrick McGovren; Langdon L Miller; Charles Erlichman
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2006;58(2):165-72.
2006: Steven R Alberts; Paul J Novotny; Jeff A Sloan; John Danella; David G Bostwick; Thomas J Sebo; Michael L Blute; Tom R Fitch; Ralph Levitt; Ronald Lieberman; Charles L Loprinzi
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
American journal of therapeutics 2006;13(4):291-7.
2006: Kostandinos Sideras; Paul L Schaefer; Scott H Okuno; Jeff A Sloan; Leila Kutteh; Tom R Fitch; Shaker R Dakhil; Ralph Levitt; Steven R Alberts; Roscoe F Morton; Kendrith M Rowland; Paul J Novotny; Charles L Loprinzi
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.
Mayo Clinic proceedings. Mayo Clinic 2006;81(6):758-67.
2006: Amanda C Ashley; Claude Deschamps; Steven R Alberts
Impact of prognostic factors on clinical outcome after resection of colorectal pulmonary metastases.
Clinical colorectal cancer 2006;6(1):32-7.
2006: Steven R Alberts; Janet J Kelly; Anne P Lanier; Frank Sacco
Occurrence of esophageal and gastric cancer in Alaska Natives, 1969-2003.
Alaska medicine 2006;48(1):2-11.
2006: M Baweja; Vera J Suman; Tom R Fitch; James A Mailliard; Albert M Bernath; Kendrith M Rowland; Steven R Alberts; J S Kaur; Edith A Perez
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):623-9.
2006: Karin F Giordano; Aminah Jatoi; Philip J Stella; Nathan Foster; Loren K Tschetter; Steven R Alberts; Shaker R Dakhil; James A Mailliard; Patrick J Flynn; Daniel A Nikcevich
Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):652-6.
2006: David P Steensma; Roy Molina; Jeff A Sloan; Daniel A Nikcevich; Paul L Schaefer; Kendrith M Rowland; Todor Dentchev; Paul J Novotny; Loren K Tschetter; Steven R Alberts; Thomas F Hogan; Amy Law; Charles L Loprinzi
Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1079-89.
2006: Aminah Jatoi; B R Murphy; Nathan R Foster; Daniel A Nikcevich; Steven R Alberts; James A Knost; Tom R Fitch; Kendrith M Rowland
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(1):29-34.
2005: Steven R Alberts; William L Horvath; William C Sternfeld; Richard M Goldberg; Michelle R Mahoney; Shaker R Dakhil; Ralph Levitt; Kendrith M Rowland; Suresh Nair; Daniel J Sargent; John H Donohue
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9243-9.
2005: Julian R Molina; Joel M Reid; Charles Erlichman; Jeff A Sloan; Alfred F Furth; Stephanie L Safgren; Chetan Lathia; Steven R Alberts
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.
Anti-cancer drugs 2005;16(9):997-1002.
2005: Steven R Alberts; Nathan R Foster; Roscoe F Morton; J Kugler; Paul Schaefer; Martin Wiesenfeld; Tom R Fitch; P Steen; George P Kim; S Gill
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1654-61.
2005: David J Rea; Julie K Heimbach; Charles B Rosen; Michael G Haddock; Steven R Alberts; Walter K Kremers; Gregory J Gores; David M Nagorney
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma.
Annals of surgery 2005;242(3):451-8; discussion 458-61.
2005: Edith A Perez; David W Hillman; Paul A. Fishkin; James E Krook; Winston W Tan; Philip Kuriakose; Steven R Alberts; Shaker R Dakhil
Phase II trial of dolastatin-10 in patients with advanced breast cancer.
Investigational new drugs 2005;23(3):257-61.
2005: Grace K Dy; Ajit Suri; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Pamela J Atherton; Lorelei J Hanson; Patrick A Burch; Joseph Rubin; Charles Erlichman; Alex A. Adjei
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2005;55(6):522-30.
2005: Grace K Dy; James P Thomas; George Wilding; Laura M Bruzek; Sumithra J Mandrekar; Charles Erlichman; Dona Alberti; Kim Binger; Henry C Pitot; Steven R Alberts; Lorelei J Hanson; Rebecca Marnocha; Kendra Tutsch; Scott H Kaufmann; Alex A. Adjei
A phase I and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib, velcade), in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3410-6.
2005: Thomas E Witzig; Peter T Silberstein; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; James A Mailliard; Kendrith M Rowland; Steven R Alberts; James E Krook; Ralph Levitt; Roscoe F Morton
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2606-17.
2005: Thierry Delaunoit; Steven R Alberts; Daniel J Sargent; Erin Green; Richard M Goldberg; James E Krook; C Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Roscoe F Morton; Brian P Findlay
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):425-9.
2005: Steven R Alberts; Hani Al-Khatib; Michelle R Mahoney; Lawrence J Burgart; Peter J Cera; Patrick J Flynn; Tom R Finch; Ralph Levitt; Harold E Windschitl; James A Knost; Loren K Tschetter
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
Cancer 2005;103(1):111-8.
2004: Steven R Alberts; Mark Schroeder; Charles Erlichman; Preston D Steen; Nathan R Foster; Dennis F Moore; Kendrith M Rowland; Suresh Nair; Loren K Tschetter; Tom R Fitch
Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4944-50.
2004: Julie K Heimbach; Michael G Haddock; Steven R Alberts; Scott L Nyberg; Michael B Ishitani; Charles B Rosen; Gregory J Gores
Transplantation for hilar cholangiocarcinoma.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(10 Suppl 2):S65-8.
2004: Sharlene Gill; Charles L Loprinzi; Daniel J Sargent; Stephan D Thomé; Steven R Alberts; Daniel G Haller; Jacqueline K Benedetti; Guido Francini; Lois E Shepherd; Jean Francois Seitz; Roberto Labianca; Wei Chen; Stephen S Cha; Michael P Heldebrant; Richard M Goldberg
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(10):1797-806.
2004: Julie K Heimbach; Gregory J Gores; Michael G Haddock; Steven R Alberts; Scott L Nyberg; Michael B Ishitani; Charles B Rosen
Liver transplantation for unresectable perihilar cholangiocarcinoma.
Seminars in liver disease 2004;24(2):201-7.
2004: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23-30.
2003: Aminah Jatoi; Vera J Suman; Paul Schaefer; Margaret Block; Charles L Loprinzi; Patrick Roche; Stuart Garneau; Roscoe Morton; Philip J Stella; Steven R Alberts; Mark Pittelkow; Jeff Sloan; Richard Pagano
A phase II study of topical ceramides for cutaneous breast cancer.
Breast cancer research and treatment 2003;80(1):99-104.
2003: Alex A. Adjei; Gary A Croghan; Charles Erlichman; Randolph S Marks; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Laura M Bruzek; Pamela J Atherton; Alain Thibault; Peter A Palmer; Scott H Kaufmann
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2520-6.
2003: Steven R Alberts; P M Townley; Richard M Goldberg; S S Cha; Daniel J Sargent; Dennis F Moore; James E Krook; Henry C Pitot; Tom R Fitch; Martin Wiesenfeld; James A Mailliard
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):580-5.
2003: Alex A. Adjei; Grace K Dy; Charles Erlichman; Joel M Reid; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Pamela J Atherton; Tanya Watanabe; Richard S Geary; Jon T Holmlund; F Andrew Dorr
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):115-23.
2002: Richard M Goldberg; Scott H Kaufmann; Pamela J Atherton; Jeff A Sloan; Alex A. Adjei; Henry C Pitot; Steven R Alberts; Joseph Rubin; L L Miller; Charles Erlichman
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1674-80.
2002: Alex A. Adjei; Joel M Reid; Charles Erlichman; Jeff A Sloan; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Stacie Ruben; Scott A Boemer; Pamela J Atherton; Matthew M Ames; Scott H Kaufmann
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
Investigational new drugs 2002;20(3):297-304.
2002: Svetomir N Markovic; Vera J Suman; Allen M Vukov; Tom R Fitch; David W Hillman; Alex A. Adjei; Steven R Alberts; Judith S Kaur; Theodore A Braich; John M Leitch; Edward T. Creagan
Phase II trial of KW2189 in patients with advanced malignant melanoma.
American journal of clinical oncology 2002;25(3):308-12.
2002: Steven R Alberts; P M Townley; Richard M Goldberg; S S Cha; Dennis F Moore; James E Krook; Henry C Pitot; Tom R Fitch; Martin Wiesenfeld; James A Mailliard; Daniel J Sargent
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):553-7.
2002: Alex A. Adjei; Joel M Reid; Robert B Diasio; Jeff A Sloan; Deborah A Smith; Joseph Rubin; Henry C Pitot; Steven R Alberts; Richard M Goldberg; Lorelei J Hanson; Pamela J Atherton; Matthew M Ames; Charles Erlichman
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1683-91.
2002: Aminah Jatoi; Maria Tria Tirona; Stephen S Cha; Steven R Alberts; Kendrith M Rowland; Roscoe F Morton; Suresh Nair; Carl G Kardinal; Philip J Stella; James A Mailliard; Daniel Sargen; Richard M Goldberg
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
International journal of gastrointestinal cancer 2002;32(2-3):115-23.
2002: Steven R Alberts; Paul A. Fishkin; Lawrence J Burgart; Peter J Cera; Michelle R Mahoney; Roscoe F Morton; Patricia A Johnson; Suresh Nair; Richard M Goldberg
CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study.
International journal of gastrointestinal cancer 2002;32(2-3):107-14.
2001: Steven R Alberts; Charles Erlichman; J Sloan; S H Okuno; Patrick A Burch; Joseph Rubin; Henry C Pitot; Richard M Goldberg; Alex A. Adjei; Pamela J Atherton; S H Kaufmann
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):627-31.
2001: Steven R Alberts; M L Blute
Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia.
Urology 2001;57(4 Suppl 1):188-90.
2001: Charles Erlichman; Alex A. Adjei; Steven R Alberts; Jeff A Sloan; Richard M Goldberg; Henry C Pitot; Joseph Rubin; Pamela J Atherton; G G Klee; R Humphrey
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):389-95.
2000: Alex A. Adjei; Charles Erlichman; Jeff A Sloan; Joel M Reid; Henry C Pitot; Richard M Goldberg; Prema P Peethambaram; Pamela J Atherton; Lorelei J Hanson; Steven R Alberts; James Jett
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1748-57.
2000: C L Loprinzi; Steven R Alberts; B J Christensen; Lorelei J Hanson; David R Farley; J K Broers; D L Betcher; R E Grady; P A Southorn; T M Johnson; E A Perez
History of the development of antiemetic guidelines at Mayo Clinic Rochester.
Mayo Clinic proceedings. Mayo Clinic 2000;75(3):303-9.
2000: Alex A. Adjei; Cheri E Klein; Helen Kastrissios; Richard M Goldberg; Steven R Alberts; Henry C Pitot; Jeff A Sloan; Joel M Reid; Lorelei J Hanson; Pamela J Atherton; Joseph Rubin; Charles Erlichman
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1116-23.
1998: Steven R Alberts; Charles Erlichman; Joel M Reid; Jeff A Sloan; Matthew M Ames; Ronald L Richardson; Richard M Goldberg
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2111-7.
1997: Steven R Alberts; Anne P Lanier
Correspondence re: G. G. Schwartz, Multiple Myeloma: Clusters, Clues, and Dioxins. Cancer Epidemiol. Biomark. Prev., 6: 49-56, 1997.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(10):857-8.